Komipharm International Co., Ltd.
Weterynaryjne API i gotowe preparaty do wstrzykiwań dla trzody chlewnej i drobiu, eksportowane do 70 krajów.
Komipharm produkuje farmaceutyki weterynaryjne, w tym amoksycylinę, florfenikol i tylmikozynę do wstrzykiwań oraz rozpuszczalne proszki. Zakład posiadający certyfikat GMP zaopatruje dystrybutorów produktów w zakresie zdrowia zwierząt i dużych integratorów w Ameryce Łacińskiej i Azji Południowo-Wschodniej.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Siheung, South Korea
- Website
- komipharm.com
- Categories
- Produkty weterynaryjne i zdrowie zwierząt
- Markets
- Brazylia, Wietnam, Indonezja, Filipiny
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- product-authorised-for-sale (green), checked 2026-08-20 NAFDAC Greenbook, Nigeria - register of authorised products (manufacturer named on the authorisation)
- sanctions-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- lei-lapsed (amber), checked 2026-08-09 GLEIF
- debarment-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-09 Domain registry record
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)